See the DrugPatentWatch profile for cosentyx

There is currently no scientific evidence to suggest that vaccine intake directly boosts the effectiveness of Cosentyx (secukinumab). Cosentyx is a medication used to treat several types of immunological diseases, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a monoclonal antibody that works by blocking the action of interleukin-17A, a protein involved in inflammation [1].

On the other hand, vaccines work by stimulating the immune system to build a response against specific infectious agents [2]. Vaccines do not directly interact with or enhance the effectiveness of medications like Cosentyx. However, it is generally recommended that individuals on immunosuppressive therapies, such as Cosentyx, stay up-to-date with recommended vaccinations to prevent infections [3].

In summary, while vaccines do not boost the effectiveness of Cosentyx, they remain crucial for maintaining overall health in individuals taking immunosuppressive medications.

Sources:
[1] "Secukinumab." Drugs.com, www.drugs.com/secukinumab.html.
[2] "Vaccines." Mayo Clinic, Mayo Foundation for Medical Education and Research, 11 Jan. 2022, www.mayoclinic.org/diseases-conditions/vaccines/symptoms-causes/syc-20351681.
[3] "Vaccines and People with Weakened Immune Systems." Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 22 Sept. 2021, www.cdc.gov/vaccines/adults/rec-vac/people-with-weakened-immune-systems.html.